Amphastar Pharmaceuticals, Inc
F:29A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Amphastar Pharmaceuticals, Inc
F:29A
|
US |
|
Banyan Tree Holdings Ltd
F:1O7
|
SG |
|
V
|
Verizon Communications Inc
F:BAC
|
US |
|
Barrick Mining Corp
SIX:B
|
CA |
|
M
|
Matsui Securities Co Ltd
XMUN:MTW
|
JP |
Intrinsic Value
Is 29A undervalued or overvalued?
See the intrinsic value estimate for 
Amphastar Pharmaceuticals, Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
29A looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with 29A’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Amphastar Pharmaceuticals Does
Amphastar Pharmaceuticals makes and sells injectable, inhalation, and intranasal medicines that are used in hospitals, emergency care, and other clinical settings. Its products include both branded and generic drugs, along with active pharmaceutical ingredients and certain drug-device combinations. The company focuses on medicines that are often hard to manufacture and supply consistently, which gives it a role in the lower-cost end of the pharmaceutical market.
- Headquarters
- United States of America US
- Employees
- 1 976
- IPO date
- Jun 25, 2014
Revenue & Expenses Breakdown
Amphastar Pharmaceuticals, Inc
Earnings Waterfall
Amphastar Pharmaceuticals, Inc
The intrinsic value for Amphastar Pharmaceuticals, Inc (29A) under the Base Case is hidden EUR.
Compared with the current market price of 23.07 EUR, the stock appears hidden.